| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Annals of Surgical Oncology, Vol 5, Issue 4 315-321, Copyright © 1998 by Society of Surgical Oncology
ARTICLES |
T. J. Miner, C. D. Shriver, D. P. Jaques, M. E. Maniscalco-Theberge and D. N. Krag
General Surgery Service, Walter Reed Army Medical Center, Washington, DC 20307, USA.
BACKGROUND: Several reports have demonstrated the accurate prediction of axillary nodal status (ANS) with radiolocalization and selective resection of sentinel lymph nodes (SLN) in breast cancer. To date, no technique has proven to be superior in localizing the SLN. METHODS: 1.0 mCi of clear unfiltered 99mtechnetium sulfur colloid was injected under ultrasonographic (US) guidance around the perimeter of the breast lesion (palpable and nonpalpable) or previous biopsy site. Resection of the radiolocalized nodes was performed, followed by complete axillary lymph node dissection (AXLND). RESULTS: Forty-two breast cancer patients underwent SLN biopsy after US-guided radiopharmaceutical injection. The SLN was localized in 41 patients (98%). The type of previously performed diagnostic biopsy did not influence the ability to localize the sentinel lymph node. Pathology revealed nodal metastasis in 7 of the 41 evaluable patients (17%). ANS was accurately predicted in 40 of 41 patients (98%). CONCLUSIONS: Early experience with radiolocalization and selective resection of SLN in breast cancer remains promising. Use of US-guided injection facilitates localization of the SLN, perhaps as a result of more accurate placement of the radionuclide marker. Use of this technique allowed for effective management of patients regardless of tumor size or the extent of prior biopsy, thereby expanding the potential number of eligible patients for SLN biopsy.
This article has been cited by other articles:
 |
|
 |
|
  S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, D. J. Carlson, A. L. Laidley, T. Q. McGlothin, P. B. Ley, C. M. Brown, et al. The Effect of Prior Breast Biopsy Method and Concurrent Definitive Breast Procedure on Success and Accuracy of Sentinel Lymph Node Biopsy Ann. Surg. Oncol., April 1, 2002; 9(3): 272 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Bauer, F. R. Spitz, L. S. Callans, A. Alavi, R. Mick, S. P. Weinstein, I. Bedrosian, D. L. Fraker, T. L. Bauer, and B. J. Czerniecki Subareolar and Peritumoral Injection Identify Similar Sentinel Nodes for Breast Cancer Ann. Surg. Oncol., March 1, 2002; 9(2): 169 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.J. Tanis, E.E. Deurloo, R.A. Valdes Olmos, E.J.Th. Rutgers, O.E. Nieweg, A.P.E. Besnard, and B.B.R. Kroon Single Intralesional Tracer Dose for Radio-Guided Excision of Clinically Occult Breast Cancer and Sentinel Node Ann. Surg. Oncol., December 1, 2001; 8(10): 850 - 855. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Cantin, H. Scarth, M. Levine, and M. Hugi Clinical practice guidelines for the care and treatment of breast cancer: 13. Sentinel lymph node biopsy Can. Med. Assoc. J., July 1, 2001; 165(2): 166 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Liberman, H. S. Cody III, A. D. K. Hill, P. P. Rosen, S. D. J. Yeh, T. Akhurst, E. A. Morris, A. F. Abramson, P. I. Borgen, and D. D. Dershaw Sentinel Lymph Node Biopsy after Percutaneous Diagnosis of Nonpalpable Breast Cancer Radiology, June 1, 1999; 211(3): 835 - 844. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. E. Giuliano Mapping a Pathway for Axillary Staging: A Personal Perspective on the Current Status of Sentinel Lymph Node Dissection for Breast Cancer Arch Surg, February 1, 1999; 134(2): 195 - 199. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
